1. Grief SN. Upper respiratory infections. Prim Care. 2013;40(3):757-70. doi: 10.1016/j.pop.2013.06.004.
2. Sexton DJ, McClain MT. The common cold in adults: treatment and prevention. UpToDate, 2020. Available from URL:https: //www.uptodate. com/ contents/the-common-cold-in-adults-treatment-and-prevention
3. Thompson M et al. Duration of symptoms of respiratory tract infections in children: Systematic review. BMJ 2013 Dec 11;347:f7027.doi: 10.1136/bmj.f7027.
4. Rondanelli M et al. Self-Care for Common Colds: The Pivotal Role of Vitamin D, Vitamin C, Zinc, and Echinacea in Three Main Immune Interactive Clusters (Physical Barriers, Innate and Adaptive Immunity) Involved during an Episode of Common Colds—Practical Advice on Dosages and on the Time to Take These Nutrients/Botanicals in order to Prevent or Treat Common Colds. Evid Based Complement Alternat Med. 2018 Apr 29;2018:5813095.doi: 10.1155 /2018/581 3095. eCollection 2018.
5. Isbaniah F, et al. Echinacea purpurea along with zinc, selenium and vitamin C to alleviate exacerbations of chronic obstructive pulmonary disease: Results from a randomized controlled trial. J Clin Pharm Ther. 2011 Oct;36(5):568-76. doi: 10.1111/j.1365-2710.2010.01212.x. Epub 2010 Nov 10
6. Erickson KL, Medina EA, and Hubbard NE. Micronutrients and innate immunity. J Infect Dis. 2000 Sep;182 Suppl 1:S5-10.doi: 10.1086/315922.
7. Nahas R, Balla A. Complementary and alternative medicine for prevention and treatment of the common cold. Can Fam Physician. 2011 Jan;57(1):31-6. PMID 21322286
8. Maywald M. Rink L. Zinc supplementation Induces CD4+ CD25+ Foxp3+ Antigen-spesific Regulatory T cells and Suppresses IFN- γ Production by Upregulation of Foxp3 and KLF-10 and Downregulation of IRF-1. Eur J Nutr. 2017;56(5):1859-1869. doi: 10.1007/s00394-016-1228-7.Epub 2016.
9. Hojyo S, Fukada T. Roles of Zinc Signaling in the Immune System. J Immunol Res. 2016;2016:6762343.doi: 10.1155/2016/6762343. Epub 2016.
10. Martinez-Estevez NS, Alvarez-Guevara AN, and Rodriguez-Martinez CE. Effects of zinc supplementation in the prevention of respiratory tract infections and diarrheal disease in Colombian children: A 12-month randomised controlled trial. Allergologia et Immunopathologia.2016;44(4): 368–375. https://doi.org /10.1016 /j.aller.2015.12.006
11. Rando HM, et al. SARS-CoV-2 and COVID-19: An Evolving Review of Diagnostics and Therapeutics. 2020. Available from URL: https://greenelab.github.io/covid19-review/
12. Singh M, Das RR. Zinc for the common cold. Cochrane Database Syst Rev. 2011;(2):CD001364. doi: 10.1002/14651858.CD001364.pub4.
13. Hamilia H. Zinc Lozenges and the Common Cold: A Meta-Analysis Comparing Zinc Acetate and Zinc Gluconate, and the Role of Zinc Dosage. JRSM Open 2017 May 2;8(5):2054270417694291. doi: 10.1177/ 20542 70417694291.eCollection 2017 May
14. Schwalfenberg GK. A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency. Mol Nutr Food Res. 2011 Jan;55(1):96-108. doi: 10.1002/mnfr.201000174.Epub 2010.
15. Bartley J. Vitamin D, innate immunity and upper respiratory tract infection. J Laryngol Otol. 2010;124(5):465-9. doi: 10.1017 /S00222 15109992684.Epub 2010
16. Kamen DL, Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. Journal of Molecular Medicine.2010; 88(5): 441–450. DOI : 10.1007/s00109-010-0590-9
17. Laaksi I, et al. Vitamin D Supplementation for the Prevention of Acute Respiratory Tract Infection: A Randomized, Double-Blinded Trial among Young Finnish Men. J Infect Dis. 2010 Sep 1;202(5):809-14. doi: 10.1086/654881.
18. Charan J, Goyal JP, Saxena D, and Yadav P. Vitamin D for prevention of respiratory tract infections: a systematic review and meta-analysis. J Pharmacol Pharmacother. 2012 Oct;3(4):300-3. doi: 10.4103/0976-500X.103685
19. Bergman P, Norlin AC, Hansen S, and Bj¨orkhem-Bergman L. Vitamin D supplementation improves well-being in patients with frequent respiratory tract infections: A post hoc analysis of a randomized, placebo-controlled trial. BMC Res Notes. 2015;8:498. doi: 10.1186/s13104-015-1504-2.
20. Camargo C, et al.Randomized Trial of Vitamin D Supplementation and Risk of Acute Respiratory Infection in Mongolia. Pediatrics. 2012;130(3):e561-7. doi: 10.1542/peds.2011-3029. Epub 2012
21. Urashima M, et al. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. American Journal of Clinical Nutrition.2010; 91 (5):1255–1260. https://doi.org/10. 3945/ajcn.2009.29094
22. Lauer AC, Groth N, Haag SF, Darvin ME, Lademann J, and Meinke MC. Dose-dependent vitamin C uptake and radical scavenging activity in human skin measured with in vivo electron paramagnetic resonance spectroscopy. Skin Pharmacol Physiol. 2013;26(3):147-54.doi: 10.1159/000350833. Epub 2013
23. Hemila H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev.2013 Jan 31;(1):CD000980. doi: 10.1002/14651858.CD000980.pub4.
24. Maggini S, Beveridge S, Suter M. A combination of high dose vitamin C plus zinc for the common cold. J Int Med Res. 2012;40(1):28-42. doi: 10.1177 /147323001204000104.
25. Vimalanathan S, Schoop R, Suter A, and Hudson J. Prevention of influenza virus induced bacterial superinfection by standardized Echinacea purpurea, via regulation of surface receptor expression in human bronchial epithelial cells. Virus Res. 2017 Apr 2;233:51-59. doi: 10.1016/j.virusres.2017.03.006.Epub 2017
26. Park S, et al. Echinacea Purpurea Protects Against Restraint Stress-Induced Immunosuppression in BALB/c Mice. J Med Food. 2018 Mar;21(3):261-268. doi: 10.1089/jmf.2017.4073. Epub 2017
27. Dapas B, et al. Immunomodulation mediated by a herbal syrup containing a standardized Echinacea root extract: A pilot study in healthy human subjects on cytokine gene expression. Phytomedicine. 2014 Sep 25;21(11):1406-10.doi: 10.1016/j.phymed.2014.04.034.Epub 2014
28. Fonseca FN, et al. Echinacea purpurea (L.) Moench modulates human T-cell cytokine response. International Immunopharmacology.2014; 19(1): 94–102. DOI: 10.1016/j.intimp.2013.12.019
29. Jawad M, Schoop R, Suter A, Klein P, and Eccles R. Safety and efficacy profile of Echinacea purpurea to prevent common cold episodes: A randomized, double-blind, placebo-controlled trial. eCAM.2012, Article ID 841315. DOI: 10.1155/2012/841315
30. Di Pierro F, et al. Use of a standardized extract from Echinacea angustifolia (Polinacea) for the prevention of respiratory tract infections. Altern Med Rev.2012;17(1):36–41.PubMed ID 22502621.
31. Karsch-Volk M, Barrett B, Kiefer D, Bauer R, Ardjomand- Woelkart K, Linde K. Echinacea for preventing and treating the common cold. Cochrane Database Sys Rev.2014; 2(2): CD000530. doi: 10.1002/14651858.CD000530.pub3.
32. Schapowal A, Klein P, Johnston SL. Echinacea Reduces the Risk of Recurrent Respiratory Tract Infections and Complications: A Meta-Analysis of Randomized Controlled Trials. Adv Ther. 2015 Mar;32(3):187-200. doi: 10.1007/s12325-015-0194-4. Epub 2015
33. Thanh Thi Ho G, Wangensteen H, Barsett H. lderberry and Elderflower Extracts, Phenolic Compounds, and Metabolites and Their Effect on Complement, RAW 264.7 Macrophages and Dendritic Cells. Int. J. Mol. Sci. 2017, 18, 584; doi:10.3390/ijms18030584
34. Ulbricht C, et al. An Evidence-Based Systematic Review of Elderberry and Elderflower (Sambucus nigra) by the Natural Standard Research Collaboration. Journal of Dietary Supplements, 11(1):80–120, 2014. DOI: 10.3109/19390211.2013.859852
35. Porter RS, Bode RF. A Review of the Antiviral Properties of Black Elder ( Sambucus nigra L.) Products. Phytother Res. 2017 Apr;31(4):533-554. doi: 10.1002/ptr.5782.Epub 2017 Feb 15.
36. Tiralongo E, Wee SS, Lea RA. Elderberry supplementation reduces cold duration and symptoms in air-travellers: A randomized, double-blind placebo-controlled clinical trial. Nutrients.2016;8(4): e182. https://doi.org/10.3390/nu8040182
37. Hawkins J, Baker C, Cherry L, Dunne E. Black elderberry (Sambucus nigra) supplementation effectively treats upper respiratory symptoms: A meta-analysis of randomized, controlled clinical trials. Complementary Therapies in Medicine. 2019; 42:361–365. DOI: 10.1016 /j.ctim. 2018.12.004.
38. Lee NY, Khoo WK, Adnan MA, Mahalingam TP, Fernandez AR, Jeevaratnam K. The pharmacological potential of Phyllanthus niruri. J Pharm Pharmacol. 2016 Aug;68(8):953-69.doi: 10.1111/jphp.12565.Epub 2016 Jun 10.
39. Tjandrawinata R, Susanto L, Nofiarny D. (2017). The use of Phyllanthus niruri L. as an immunomodulator for the treatment of infectious diseases in clinical settings. Asian Pacific Journal of Tropical Disease.2017;7:132-140. DOI: 10.12980/apjtd.7.2017D6-287.
40. Nworu CS, Akah PA, Okoye FB, Proksch P, Esimone CO. The effects of Phyllanthus niruri aqueous extract on the activation of murine lymphocytes and bone marrow-derived macrophages. Immunol Invest 2010; 39(3): 245-67. DOI: 10.3109/08820131003599585.
41. Kusumaningrum ADR, Sumadiono, Soenarto Y. Effects of Phyllanthus niruri on the severity of the common cold in children. Paediatr Indones. 2012;52:346-51. DOI: 10.14238/pi52.6.2012.346-51.